tiprankstipranks
Trending News
More News >
Republic Healthcare Limited (HK:8357)
:8357
Hong Kong Market

Republic Healthcare Limited (8357) AI Stock Analysis

Compare
0 Followers

Top Page

HK

Republic Healthcare Limited

(8357)

Rating:60Neutral
Price Target:
Republic Healthcare Limited shows financial stability with strong equity positions and low debt, but faces significant challenges due to declining revenues and losses. The technical analysis indicates the stock is overbought, which may lead to a correction. Valuation is a concern due to negative earnings, making the stock less attractive. Overall, while there are some operational improvements, the risks and valuation concerns limit the stock's appeal.

Republic Healthcare Limited (8357) vs. iShares MSCI Hong Kong ETF (EWH)

Republic Healthcare Limited Business Overview & Revenue Model

Company DescriptionRepublic Healthcare Limited (8357) is a healthcare services company that operates within the medical sector, focusing on providing quality healthcare solutions. The company is known for offering a wide range of medical services, including general practitioner consultations, specialist medical services, and other healthcare-related offerings designed to cater to diverse patient needs.
How the Company Makes MoneyRepublic Healthcare Limited generates revenue primarily through its provision of medical services. The company earns money by charging patients for consultations with general practitioners and specialists, as well as for various medical procedures and treatments offered at its facilities. Additionally, the company may have partnerships with healthcare providers and insurance companies, which can facilitate patient referrals and reimbursements, thus contributing to its earnings. Revenue can also be derived from ancillary services, such as diagnostic tests and preventive healthcare programs. These diversified revenue streams enable the company to maintain a stable financial performance.

Republic Healthcare Limited Financial Statement Overview

Summary
Republic Healthcare Limited demonstrates strong equity positions with low leverage, which provides financial stability. However, declining revenues and persistent net losses pose significant challenges. Operational improvements are visible, but sustained profitability remains a concern.
Income Statement
65
Positive
Revenue has declined over the past three years, with a negative revenue growth rate and shrinking gross profit margin from 72.1% in 2019 to 24.4% in 2024. The net profit margin is negative, indicating losses. However, the company improved its EBIT margin from negative to 18.42% in 2024, showing some operational efficiency.
Balance Sheet
75
Positive
The company maintains a strong equity position with an equity ratio consistently above 80%. Debt-to-equity ratio is low at 0.068, indicating low financial leverage. However, the return on equity is negative due to net losses, which presents a challenge for profitability.
Cash Flow
60
Neutral
The free cash flow has fluctuated, with a decline in free cash flow growth rate in recent periods. The operating cash flow to net income ratio is positive, indicating operational cash generation despite accounting losses. However, the free cash flow to net income ratio is inconsistent, reflecting variability in capital management.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue9.23M10.00M9.04M13.37M13.72M
Gross Profit6.48M6.83M5.97M9.13M9.83M
EBITDA-188.79K29.34K-387.88K962.89K1.43M
Net Income-178.16K-855.12K-1.47M-997.93K65.90K
Balance Sheet
Total Assets14.48M15.64M16.42M19.27M19.34M
Cash, Cash Equivalents and Short-Term Investments11.52M11.93M11.83M14.14M13.07M
Total Debt858.22K961.16K810.47K1.55M2.76M
Total Liabilities1.93M2.89M2.30M3.67M6.09M
Stockholders Equity12.55M12.75M14.12M15.59M13.26M
Cash Flow
Free Cash Flow51.27K806.24K-1.16M-1.13M232.36K
Operating Cash Flow125.07K899.91K-734.46K-510.07K771.30K
Investing Cash Flow-93.94K831.49K-987.23K-1.56M7.62M
Financing Cash Flow-531.65K-587.62K-689.73K2.28M-1.36M

Republic Healthcare Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.17
Price Trends
50DMA
0.12
Positive
100DMA
0.09
Positive
200DMA
0.08
Positive
Market Momentum
MACD
0.02
Positive
RSI
61.89
Neutral
STOCH
13.89
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8357, the sentiment is Positive. The current price of 0.17 is above the 20-day moving average (MA) of 0.15, above the 50-day MA of 0.12, and above the 200-day MA of 0.08, indicating a bullish trend. The MACD of 0.02 indicates Positive momentum. The RSI at 61.89 is Neutral, neither overbought nor oversold. The STOCH value of 13.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8357.

Republic Healthcare Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (60)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
60
Neutral
HK$15.14B5.55-7.43%4.45%11.60%-21.06%
60
Neutral
HK$106.08M-1.41%-13.38%78.75%
51
Neutral
HK$163.46M-18.22%-56.16%62.50%
45
Neutral
HK$143.51M-12.06%4.62%-60.86%
44
Neutral
HK$20.84M107.650.88%8.34%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8357
Republic Healthcare Limited
0.17
0.08
88.89%
HK:8267
Linekong Interactive Group Co., Ltd.
0.39
0.05
14.71%
HK:8186
M-Resources Group Limited
0.18
-0.84
-82.35%
HK:8143
Good Fellow Healthcare Holdings Limited
0.14
-0.05
-26.32%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Apr 20, 2025